Hyperglycemia as an effect of cardiopulmonary bypass: Intra-operative glucose management

Journal of Extra-Corporeal Technology

Volumn 38, Issue 2, 2006, Pages 168-173

  Najmaii, Samira ^a   Redford, Daniel ^a   Larson, Douglas F ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Glucose; GLUT2; GLUT4; Glycogen; Hyperglycemia; Hyperoxia; Hypothermia; Insulin

Indexed keywords

CATECHOLAMINE; GLUCOSE; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; GLYCOGEN; HEPARIN; INSULIN;

BLOOD CLOTTING; CARDIOPULMONARY BYPASS; GLUCONEOGENESIS; HEART DISEASE; HEART FUNCTION; HUMAN; HYPERGLYCEMIA; HYPEROXIA; HYPOTHERMIA; INFECTION; LIVER CELL; MORTALITY; MUSCLE; NEUROLOGICAL COMPLICATION; PANCREAS ISLET BETA CELL; REVIEW; SURGICAL STRESS; CORONARY ARTERY BYPASS GRAFT; METHODOLOGY; PEROPERATIVE CARE;

CORONARY ARTERY BYPASS; GLUCOSE; HUMANS; HYPERGLYCEMIA; INTRAOPERATIVE CARE;

EID: 33749080139     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Anderson RE, Brismar K, Barr G, et al. Effects of cardiopulmonary bypass on glucose homeostasis after coronary artery bypass surgery. Eur J Cardiothorac Surg. 2005;28:425-30.
2. Velissaris T, Tang AT, Murray M, et al. A prospective randomized study to evaluate stress response during beating-heart and conventional coronary revascularization. Ann Thorac Surg. 2004;78:506-12.
3. Ruesch S, Levy J. The postcardiopulmonary bypass period: A systems approach. In: Hensley F, Martin D, Gravlee G, eds. A Practical Approach to Cardiac Anesthesia. Philadelphia, PA: Lippincott Williams and Wilkins; 2003; 235-49.
4. Doenst T, Wijeysundera D, Karkouti K, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005;130:1144.
5. Lazar HL. Hyperglycemia during cardiac surgery. J Thorac Cardiovasc Surg. 2006;131:11-3.
6. Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52:20-8.
7. Fonseca VA. Management of diabetes mellitus and insulin resistance in patients with cardiovascular disease. Am J Cardiol. 2003;92:50J-60J.
8. Trick WE, Scheckler WE, Tokars JI, et al. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2000;119:108-14.
9. Carr JM, Sellke FW, Fey M, et al. Implementing tight glucose control after coronary artery bypass surgery. Ann Thorac Surg. 2005;80:902-9.
10. Thorens B. GLUT2 in pancreatic and extra-pancreatic glucodetection (review). Mol Membr Biol. 2001;18:265-73.
11. Zaninetti D, Greco-Perotto R, Assimacopoulos-Jeannet F, et al. Effects of insulin on glucose transport and glucose transporters in rat heart. Biochem J. 1988;250:277-83.
12. Sun D, Nguyen N, DeGrado TR, et al. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation. 1994;89:793-8.
13. Fischer Y, Thomas J, Holman GD, et al. Contraction-independent effects of catecholamines on glucose transport in isolated rat cardiomyocytes. Am J Physiol. 1996;270:C1204-10.
14. Martinez-Riquelme AE, Allison SP. Insulin revisited. Clin Nutr. 2003;22:7-15.
15. Huang MT, Lee CF, Dobson GP. Epinephrine enhances glycogen turnover and depresses glucose uptake in vivo in rat heart. FASEB J. 1997;11:973-80.
16. Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab. 1982;54:131-8.
17. Mallet ML. Pathophysiology of accidental hypothermia. QJM. 2002;95:775-85.
18. Zydlewski AW, Hasbargen JA. Hypothermia-induced hypokalemia. Mil Med. 1998;163:719-21.
19. Plavinik FL, Rodrigues CI, Zanella MT, et al. Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy. Hypertension. 1992;19:II26-9.
20. Bandali KS, Belanger MP, Wittnich C. Is hyperglycemia seen in children during cardiopulmonary bypass a result of hyperoxia? J Thorac Cardiovasc Surg. 2001;122:753-8.
21. Bandali KS, Belanger MP, Wittnich C. Does hyperoxia affect glucose regulation and transport in the newborn? J Thorac Cardiovasc Surg. 2003;126:1730-5.
22. Krones A, Kietzmann T, Jungermann K. Periportal localization of glucagon receptor mRNA in rat liver and regulation of its expression by glucose and oxygen in hepatocyte cultures. FEBS Lett. 1998;421:136-40.
23. Wittnich C, Dewar ML, Chiu RC. Myocardial protection: heparin-induced free fatty acid elevation during cardiopulmonary bypass and its prevention. J Surg Res. 1984;36:527-31.
24. Jaume JC, Mendel CM, Frost PH, et al. Extremely low doses of heparin release lipase activity into the plasma and can thereby cause artifactual elevations in the serum-free thyroxine concentration as measured by equilibrium dialysis. Thyroid. 1996;6:79-83.
25. Dresner A, Laurent D, Marcucci M, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest. 1999;103:253-9.
26. Kim JK, Wi JK, Youn JH. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats. Diabetes. 1996;45:446-53.
27. Herreros J, Berjano EJ, Sola J, et al. Injury in organs after cardiopulmonary bypass: A comparative experimental morphological study between a centrifugal and a new pulsatile pump. Artif Organs. 2004;28:738-42.
28. Rassias AJ, Givan AL, Marrin CA, et al. Insulin increases neutrophil count and phagocytic capacity after cardiac surgery. Anesth Analg. 2002;94:1113-9.
29. Estrada CA, Young JA, Nifong LW, et al. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2003;75:1392-9.
30. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093-129.
31. Quinn DW, Pagano D, Bonser RS, et al. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. J Thorac Cardiovasc Surg. 2006;131:34-42.
32. Quinn DW, Pagano D, Bonser RS. Glucose and insulin influences on heart and brain in cardiac surgery. Semin Cardiothorac Vasc Anesth. 2005;9:173-8.
33. Trence DL, Kelly JL, Hirsch IB. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: Time for change. J Clin Endocrinol Metab. 2003;88:2430-7.
34. Dalla VM, Mussap M, Gallina P, et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol. 2005;16(Suppl 1):S78-82.
35. Carr ME. Diabetes mellitus: A hypercoagulable state. J Diabetes Complications. 2001;15:44-54.
36. Yamagishi S, Imaizumi T. Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des. 2005;11:2279-99.
37. Murkin JM. Pro: tight intraoperative glucose control improves outcome in cardiovascular surgery. J Cardiothorac Vasc Anesth. 2000;14:475-8.
38. Pallas F, Larson DF. Cerebral blood flow in the diabetic patient. Perfusion. 1996;11:363-70.
39. Chaney MA, Nikolov MP, Blakeman BP, et al. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesth Analg. 1999;89:1091-5.
40. Binder G, Bosk A, Gass M, et al. Insulin tolerance test causes hypokalaemia and can provoke cardiac arrhythmias. Horm Res. 2004;62:84-7.